Signal · Product Feed

NVP-BEP800 Catalog No.:M7899-2 and combination therapy resulted in

NVP-BEP800 Catalog No.:M7899-2 and combination therapy resulted in

Name: NVP-BEP800 Catalog No.:M7899-2 and combination therapy resulted in
Brand: gaabil.dk
SKU: 61222495141
Price: 120.00 USD
Availability: InStock
Rating: 4.1530000000000005 (8 reviews)

SKU: 61222495141

4.2

USD120.00 USD161.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 2 - Sep 7

Live Spec

NVP-BEP800 Catalog No.:M7899-2 and combination therapy resulted inNVP BEP800, also known as BEP 800, is a novel, fully synthetic, orally bioavailable inhibitor that binds to the NH(2) terminal ATP binding pocket of Hsp90. NVP BEP800 showed activity against a panel of human tumor cell lines and primary human xenografts in vitro at nanomolar concentrations. In A375 melanoma and BT 474 breast cancer cell lines, NVP BEP800 induced client protein degradation (including ErbB2, B Raf(V600E), Raf 1, and Akt) and Hsp70

Store: gaabil.dk · Domain: gaabil.dk

Description

and combination therapy resulted in the greatest tumor weight reduction

1-dioxo-3-[(pyridin-2-yl)carbamoyl]-2H-1

2019 Oct 10

2007 Oct 28

Omarigliptin

Exchange/Return Notes